Multiple Myeloma in the non-transplant setting (1/2)

Prof Meletios Dimopoulos, Prof Jesús San Miguel, Prof Pieter Sonneveld, Prof Heinz Ludwig
Multiple Myeloma in the non-transplant setting (1/2) ( Prof Meletios Dimopoulos, Prof Jesús San Miguel, Prof Pieter Sonneveld, Prof Heinz Ludwig )
24 May 2011

International Myeloma Workshop highlights and ongoing IMF studies

Prof Thierry Facon - Centre Hospitalier Universitaire, Lille, France
International Myeloma Workshop highlights and ongoing IMF studies ( Prof Thierry Facon - Centre Hospitalier Universitaire, Lille, France )
20 May 2011

Lenalidomide and dexamethasone to delay progression of smouldering multiple myeloma

Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain
Lenalidomide and dexamethasone to delay progression of smouldering multiple myeloma ( Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain )
20 May 2011

Flexible dosing of bortezomib for multiple myeloma

Prof Michel Delforge - Catholic University, Leuven, Belgium
Flexible dosing of bortezomib for multiple myeloma ( Prof Michel Delforge - Catholic University, Leuven, Belgium )
20 May 2011

Tailoring therapy in elderly myeloma patients

Prof Antonio Palumbo (University of Turin, Italy), Dr Keith Stewart (Mayo Clinic, Arizona, USA)
Tailoring therapy in elderly myeloma patients ( Prof Antonio Palumbo (University of Turin, Italy), Dr Keith Stewart (Mayo Clinic, Arizona, USA) )
7 May 2011

Lenalidomide survival benefit as continuous therapy for multiple myeloma

Prof Gareth Morgan, Dr Philip McCarthy
Lenalidomide survival benefit as continuous therapy for multiple myeloma ( Prof Gareth Morgan, Dr Philip McCarthy )
7 May 2011

Oncoproteins and genes involved in the chromosomal translocations of APL

Prof Pier-Paolo Pandolfi - Harvard Medical School, Boston, USA
Oncoproteins and genes involved in the chromosomal translocations of APL ( Prof Pier-Paolo Pandolfi - Harvard Medical School, Boston, USA )
21 Apr 2011

The Cancer Genome Atlas (TCGA)

Dr Paul Spellman - National Cancer Institute, Bethesda, USA
The Cancer Genome Atlas (TCGA) ( Dr Paul Spellman - National Cancer Institute, Bethesda, USA )
21 Apr 2011

AACR 2011: New Phase I targeted cancer drugs

Dr Lori Friedman - Genentech, California, USA
AACR 2011: New Phase I targeted cancer drugs ( Dr Lori Friedman - Genentech, California, USA )
20 Apr 2011

Psycho-social aspects of treating elderly patients: Expert roundtable

Prof Antonello Pinto, Dr Luzia Travado, Giora Sharf, Prof Joerg Hasford, Prof Gordon McVie
Psycho-social aspects of treating elderly patients: Expert roundtable ( Prof Antonello Pinto, Dr Luzia Travado, Giora Sharf, Prof Joerg Hasford, Prof Gordon McVie )
14 Apr 2011

Management of elderly lymphoma patients: Expert Roundtable

Prof Pier Luigi Zinzani, Prof Umberto Vitolo, Prof Bertrand Coiffier, Prof Miguel Canales, Prof Mathias Rummel
Management of elderly lymphoma patients: Expert Roundtable ( Prof Pier Luigi Zinzani, Prof Umberto Vitolo, Prof Bertrand Coiffier, Prof Miguel Canales, Prof Mathias Rummel )
14 Apr 2011

Treatment of elderly multiple myeloma patients: Expert Roundtable

Prof Antonio Palumbo, Prof Jesús San Miguel, Dr Evangelos Terpos, Prof Meral Beksac, Prof Fernando da Costa, Prof Michel Delforge
Treatment of elderly multiple myeloma patients: Expert Roundtable ( Prof Antonio Palumbo, Prof Jesús San Miguel, Dr Evangelos Terpos, Prof Meral Beksac, Prof Fernando da Costa, Prof Michel Delforge )
14 Apr 2011